Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price11.71 USD
Fair value13.30
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-11-01Read Distribution10.51+11.4% to today Markdown gives way to Distribution after a 45% slide in 11 weeks
2026-08-13Read Markdown19.11-38.7% to today ✓First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Suncrete, Inc. holds its Distribution at $11.71. Consolidating, no directional conviction, held for 3 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 3 days
Price at the screen
$11.71
Valuation
34.82 trailing · 36.15 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.72
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
49.84%
Below 33%
Interest-bearing debt is 49.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
10.83%
Below 49%
Money owed to the company is 10.8% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Suncrete,'s business is in a permissible area, but its interest-bearing debt is about 50% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RMIX's ethical verdict changes
Today RMIX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 16% discount to our $13.30 fair value, 146.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 12.0% discount to the base estimate.
Where our models see it going: fair-value estimate $13.30, with a range of $13.30 to $15.29, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sunbelt concrete logistics priced well beyond its worth
Every time a new road or housing estate rises in the Sunbelt, Suncrete moves the ready-mix that makes it possible. Yet the shares sit at nineteen dollars fifty eight against a fair value of thirteen dollars eighty six, leaving no margin of safety and an opportunity rating of none despite the ethical screen clearing cleanly.
Revenue growth of thirty nine percent looks brisk, but a one percent profit margin and one percent return on equity show how little of that top line converts into returns for owners. The forward price to earnings ratio of forty four times leaves scant room for the bumps that always arrive in building materials.
This remains a cyclical industry where strong analyst targets of twenty four dollars can coincide with peak earnings that later compress. Low profitability plus an elevated multiple together suggest the valuation already assumes the best possible outcome. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
RMIX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. The street (5 analysts) rates it strong buy, with a mean price target of $22.
2026-10-22Markdown$10.19-23.0%Entry 4
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 23.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. The street (5 analysts) rates it strong buy, with a mean price target of $22.
2026-10-02Markdown$13.23-25.9%Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 25.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. The street (5 analysts) rates it strong buy, with a mean price target of $22. Since the last review it its composite score rose; entered the Titan Ethical 500.
2026-09-13Markdown$17.86-6.5%Entry 2
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. The street (5 analysts) rates it strong buy, with a mean price target of $22.
2026-08-13Markdown$19.11Entry 1
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. The street (5 analysts) rates it strong buy, with a mean price target of $22.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.